Proangiogenic microtemplated fibrin scaffolds containing aprotinin promote improved wound healing responses

Temporal and Pharmacological Characterization of Angiostatin Release and Generation by Human Platelets: Implications for Endothelial Cell Migration

(2013) Aneta Radziwon-Balicka et al.   PLoS One

Prevascularized Microtemplated Fibrin Scaffolds for Cardiac Tissue Engineering Applications

(2013) Kassandra S. Thomson et al.   TISSUE ENGINEERING PART A

Engineering biomaterials to integrate and heal: The biocompatibility paradigm shifts

(2012) James D. Bryers et al.   BIOTECHNOLOGY AND BIOENGINEERING

Fibrin as a scaffold for cardiac tissue engineering

(2011) Maria Chiara Barsotti et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture

(2011) Nathaniel L. Tulloch et al.   CIRCULATION RESEARCH

Review paper: Critical Issues in Tissue Engineering: Biomaterials, Cell Sources, Angiogenesis, and Drug Delivery Systems

(2011) Hojjat Naderi et al.   JOURNAL OF BIOMATERIALS APPLICATIONS

Reproducible subcutaneous transplantation of cell sheets into recipient mice

(2011) Haruko Obokata et al.   Nature Protocols

Biological and Biomechanical Effects of Fibrin Injection Into Porcine Intervertebral Discs

(2011) Zorica Buser et al.   SPINE

Engineered aprotinin for improved stability of fibrin biomaterials

(2010) Kristen M. Lorentz et al.   BIOMATERIALS

A comparison of the mechanical, kinetic, and biochemical properties of fibrin clots formed with two different fibrin sealants

(2010) William L Hickerson et al.   BLOOD COAGULATION & FIBRINOLYSIS

Proangiogenic scaffolds as functional templates for cardiac tissue engineering

(2010) L. R. Madden et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component

(2009) Bryan N. Brown et al.   BIOMATERIALS

Physiological function and transplantation of scaffold-free and vascularized human cardiac muscle tissue

(2009) K. R. Stevens et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tranexamic Acid—An Alternative to Aprotinin in Fibrin-Based Cardiovascular Tissue Engineering

(2009) Eva Cholewinski et al.   TISSUE ENGINEERING PART A

Aprotinin Exerts Differential and Dose-Dependent Effects on Myocardial Contractility, Oxidative Stress, and Cytokine Release After Ischemia-Reperfusion

(2008) Matthew D. McEvoy et al.   ANNALS OF THORACIC SURGERY

Hydrogel-based Engineered Skeletal Muscle Grafts Normalize Heart Function Early After Myocardial Infarction

(2008) Marie-Noëlle Giraud et al.   ARTIFICIAL ORGANS

Aprotinin stimulates angiogenesis and human endothelial cell migration through the growth factor pleiotrophin and its receptor protein tyrosine phosphatase β/ζ

(2008) Marina Koutsioumpa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Prevascularization of a Fibrin-Based Tissue Construct Accelerates the Formation of Functional Anastomosis with Host Vasculature

(2008) Xiaofang Chen et al.   TISSUE ENGINEERING PART A

Fibrin: A Versatile Scaffold for Tissue Engineering Applications

(2008) Tamer A.E. Ahmed et al.   TISSUE ENGINEERING PART B-REVIEWS